Addictive Behaviors Reports,
Journal Year:
2022,
Volume and Issue:
15, P. 100413 - 100413
Published: Feb. 8, 2022
Methods
of
cannabis
engagement
have
proliferated
in
recent
years,
which
many
self-report
measures
do
not
adequately
capture.
There
is
a
clear
need
for
that
capture
current
patterns
use
across
range
methods,
and
can
be
used
to
track
changes
over
time.
The
study
developed
the
Cannabis
Engagement
Assessment
(CEA),
measure
past
month
dry
flower,
concentrate,
edible
products.
A
sample
349
participants
from
undergraduate
student
population
broader
community
were
recruited.
To
examine
convergent
validity
CEA,
completed
engagement,
misuse,
use-related
problems.
assess
divergent
validity,
also
depression
alcohol
Criterion
test–retest
reliability
examined
subset
65
who
re-completed
CEA
timeline
follow-back
interview
(TLFB).
Indicators
frequency
quantity
showed
good
convergence
with
patterns,
problematic
Divergent
was
supported
by
lower
associations
problems
symptoms.
estimates
TLFB.
viable
representative
recreational
engagement.
Its
focus
on
preceding
30
days
lends
itself
measuring
Addiction,
Journal Year:
2021,
Volume and Issue:
117(6), P. 1510 - 1517
Published: Sept. 30, 2021
Abstract
Background
The
lack
of
an
agreed
international
minimum
approach
to
measuring
cannabis
use
hinders
the
integration
multidisciplinary
evidence
on
psychosocial,
neurocognitive,
clinical
and
public
health
consequences
use.
Methods
A
group
25
expert
researchers
convened
discuss
a
framework
for
standards
measure
globally
in
diverse
settings.
Results
expert‐based
consensus
upon
three‐layered
hierarchical
framework.
Each
layer—universal
measures,
detailed
self‐report
biological
measures—reflected
different
research
priorities
standards,
costs
ease
implementation.
Additional
work
is
needed
develop
valid
precise
assessments.
Conclusions
Consistent
proposed
across
research,
health,
practice
medical
settings
would
facilitate
harmonisation
consumption,
related
harms
approaches
their
mitigation.
Frontiers in Neuroimaging,
Journal Year:
2023,
Volume and Issue:
2
Published: March 7, 2023
Cannabis
is
the
most
widely
used
regulated
substance
by
youth
and
adults.
use
has
been
associated
with
psychosocial
problems,
which
have
partly
ascribed
to
neurobiological
changes.
Emerging
evidence
date
from
diffusion-MRI
studies
shows
that
cannabis
users
compared
controls
show
poorer
integrity
of
white
matter
fibre
tracts,
structurally
connect
distinct
brain
regions
facilitate
neural
communication.
However,
recent
thus
far
yet
be
integrated.
Therefore,
it
unclear
if
differences
in
are
evident
consistently
selected
locations,
specific
metrics,
whether
these
metrics
exposure
levels.We
systematically
reviewed
results
imaging
between
controls.
We
also
examined
associations
other
behavioral
variables
due
changes
matter.
Our
review
was
pre-registered
PROSPERO
(ID:
258250;
https://www.crd.york.ac.uk/prospero/).We
identified
30
including
1,457
1,441
aged
16-to-45
years.
All
but
6
reported
group
integrity.
The
consistent
were
lower
fractional
anisotropy
within
arcuate/superior
longitudinal
fasciculus
(7
studies),
corpus
callosum
(6
studies)
as
well
higher
mean
diffusivity
trace
(4
studies).
Differences
onset
especially
(3
studies).The
mechanisms
underscoring
unclear,
they
may
include
effects
during
youth,
neurotoxic
or
neuro
adaptations
regular
tetrahydrocannabinol
(THC),
exerts
its
binding
receptors,
a
vulnerability
predating
use.
Future
multimodal
neuroimaging
studies,
recently
developed
advanced
can
track
over
time
define
precision
when
region
commence
users,
cessation
recovers
differences.www.crd.york.ac.uk/prospero/,
identifier:
258250.
Addictive Behaviors,
Journal Year:
2023,
Volume and Issue:
144, P. 107740 - 107740
Published: April 24, 2023
Cannabis
potency
(concentration
of
Δ-9-Tetrahydrocannabinol)
has
been
associated
with
risks
adverse
mental
health
outcomes
and
addiction
but
no
studies
have
triangulated
evidence
from
self-report
objective
measures
cannabis
potency.
We
hypothesised
that
users
high
would
higher
levels
(a)
anxiety,
(b)
depression
(c)
psychosis-like
symptoms
(d)
dependence
than
lower
cannabis.A
cross-sectional
study
410
participants
donated
a
sample
for
analysis
THC
concentration
reported
their
preference.
These
two
exposure
were
investigated
association
dependence,
depression,
in
separate
linear/logistic
regression
models.High
preference
was
slight
increased
risk
after
adjusting
confounding,
the
exception
use
frequency
(OR
=
1.16,
95%
CI
1.04-1.28).
No
found
between
dependence.
There
weak
small
anxiety.
or
symptoms.Users
who
preferred
types
might
be
at
problematic
use.
This
should
considered
caution
as
we
not
able
to
triangulate
these
results
an
measure
More
research
is
needed
understand
Drug and Alcohol Dependence,
Journal Year:
2024,
Volume and Issue:
263, P. 111401 - 111401
Published: July 27, 2024
Recent
research
suggests
that
epigenetic
modifications
may
mediate
the
behavioral
effects
of
cannabis,
influencing
exocannabinnoids'
long
term
in
cognitive
function
and
its
role
emergence
psychotic
symptoms.
In
this
systematic
scoping
review,
we
assessed
current
evidence
associated
with
use
cannabis
or
exocannabinoid
administration
their
relationship
emotional
We
searched
PubMed,
Cochrane
CENTRAL,
Web
Science,
up
to
January
2022,
using
terms
"cannabis"
"epigenetics."
The
search
yielded
178
articles,
which
43
underwent
full
article
revision;
37
articles
were
included
review.
gathered
observational
cross-sectional
studies
conducted
on
human
subjects
experimental
designs
animal
models
conveyed
disparity
dosage,
methods
assessment
targeted
mechanisms.
Nine
performed
epigenome-wide
analysis
identification
differentially
methylated
sites;
most
these
found
a
global
hypomethylation,
enrichment
genes
related
cellular
survival
neurodevelopment.
Other
methylation
at
specific
exposure
was
reduced
Cg05575921,
DNMT1,
DRD2,
COMT,
DLGAP2,
Arg1,
STAT3,
MGMT,
PENK,
while
hypermethylation
DNMT3a/b,
NCAM1,
AKT1.
review
an
exocannabinoid-induced
changes
modulate
depressive-anxious,
psychotic,
addictive
behavioural
phenotypes.
Further
will
require
dosage
exposure/administration
uniformization
customized
pool
assess
suitability
as
biomarkers
for
psychiatric
diseases.
Psychopharmacology,
Journal Year:
2024,
Volume and Issue:
241(6), P. 1237 - 1244
Published: Feb. 26, 2024
As
cannabis
potency
and
use
are
increasing
in
newly
legalized
markets,
it
is
increasingly
important
to
measure
examine
the
effects
of
cannabinoid
exposure.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 15, 2025
Measuring
the
quantity
of
marijuana
flower
use
is
challenging
and
there
no
standardized
method
measurement,
yet
it
critical
for
cannabis
researchers
investigating
its
effects
on
health
outcomes.
We
sought
to
identify
frequency
used
per
day,
average
size
a
joint,
blunt
or
bowl,
amount
consumed
hit.
also
examine
distribution
heavy
daily
in
terms
grams
day.
As
part
Marijuana
Associated
Planning
Long-term
Effects
(MAPLE)
longitudinal
cohort
study,
an
underrepresented,
population
persons
with
HIV
(PWH),
who
were
users
(n
=
253)
(60.1%
Age
≥50,
54.4%
Male,
66.4%
Black)
completed
retrospective,
calendar-based
timeline
follow-back
(TLFB)
measure.
Participants
reported
their
grams,
number
hits
dose,
methods
consumption
during
30
days
prior
each
study
visit.
Of
253
participants,
208
(82%)
exclusively
52%
daily,
median
0.8
grams/day.
The
most
common
blunts
(33%,
1.0
grams),
joints
(32%,
0.5
bowls
(12%,
0.3
grams).
hit
was
0.063
grams.
proportion
had
at
least
one
day
month,
every
month
30%
6%
when
defined
as
3
grams/day,
43%
13%
2
59%
23%
1
gram/day.
Our
results
this
underrepresented
PWH
are
similar
others
defining
hit,
joint
healthy,
young
white,
male
populations.
However,
bowl
smaller
than
commonly
reported.
Over
half
sample
greater
gram/day
previous
almost
quarter
gram
month.